Egypt’s pharmaceutical market jumps 43% in 2024

Egypt’s pharmaceutical market surged to EGP 309 billion ($6.5 billion) in 2024, marking 43% year-on-year growth, according to the Egyptian Drug Authority (EDA), Daily News Egypt reports. The announcement came during the EDA’s board meeting, where officials also reviewed progress on digital transformation and regulatory reform.

Egypt has emerged as a regional pharmaceutical hub, with WHO awarding the EDA “Maturity Level 3” status for medicines and vaccines, signaling strong regulatory capacity. Its labs have also gained accreditation from the EU and WHO. The African Union has named the EDA’s training center a Regional Centre of Regulatory Excellence.

Through its expanded training programs, Egypt has provided regulatory support to countries including Libya, Ghana, and Algeria. A new learning platform aims to enhance professional development across the sector. Officials say these initiatives are critical to positioning Egypt as both a pharmaceutical manufacturing base and a continental leader in drug regulation.